DBV Technologies | DBVT - Interest Income

Stock Price
18.73
Daily Change
-0.92 -4.68%
Monthly
-10.81%
Yearly
73.43%
Q2 Forecast
19.19

DBV Technologies reported $-0.32 in Interest Income for its fiscal quarter ending in September of 2024.





Interest Income Change Date
Acadia Pharmaceuticals USD 8.33M 86K Dec/2025
Alnylam Pharmaceuticals USD 26.63M 2.05M Dec/2025
Amarin USD 3.37M 3.37M Dec/2024
BioCryst Pharmaceuticals USD -0.13 3.59M Dec/2024
BioMarin Pharmaceutical USD 22.56M 3.35M Mar/2026
DBV Technologies USD -0.32 0.02 Sep/2024
Esperion Therapeutics USD -0.15 0.18 Sep/2024
Galectin Therapeutics USD -2.71M 2.77M Dec/2023
Incyte USD 33.69M 2.93M Mar/2026
Insmed USD 765K 55K Sep/2024
Ionis Pharmaceuticals USD -0.66 0.29 Dec/2024
Sarepta Therapeutics USD 8.74M 359K Dec/2025
Ultragenyx Pharmaceutical USD 6.51M 649K Dec/2025
United Therapeutics USD 43.2M 3.2M Dec/2025